BioCentury
ARTICLE | Company News

Aerocrine, Apieron deal

May 24, 2010 7:00 AM UTC

Aerocrine acquired fellow diagnostic company Apieron's business and IP assets in a Chapter 7 bankruptcy auction for an undisclosed sum. As a result, Apieron's litigation against Aerocrine in the U.S. and Germany will be dismissed, excluding Aerocrine's infringement claims in the U.S. alleging that Apieron's Insight eNO system infringed Aerocrine's patents covering its Niox Mino and Niox Flex tests. All three products measure exhaled nitric oxide in asthma patients' breath as a measure of airway inflammation. ...